MedTrace Logo

Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter

NCT02699034 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-02-06

No results posted yet for this study

Summary

The purpose of this clinical study is to evaluate the and performance of the Imricor Medical Systems, Inc. (Imricor) MR Ablation Catheter when used with related accessories for the treatment of type I atrial flutter. The Vision Ablation Catheter and its accessories have been designed for use under fluoroscopic or magnetic resonance guidance. The study will be a single center study conducted at the Leipzig University Hospital Heart Center in Germany. The study population will consist of adult patients requiring ablation for type I atrial flutter.

Conditions

  • Atrial Flutter

Interventions

PROCEDURE

ablation for typical atrial flutter

DEVICE

Vision-MR ablation catheter

Sponsors & Collaborators

  • Heart Center Leipzig - University Hospital

    collaborator OTHER

  • Philips Healthcare

    collaborator INDUSTRY

  • Imricor Medical Systems

    collaborator INDUSTRY

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Gerhard Hindricks, MD · Heart Center Leipzig

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-06-05
Completion
2016-10-05

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02699034 on ClinicalTrials.gov